Table 1 Sample characteristics
From: Perceval-S over time. Clinical outcomes after ten years of usage
Ν (%) | |
|---|---|
Sex | |
Men | 70 (34.1) |
Women | 135 (65.9) |
Age, mean (SD) | 76.4 (6.1) |
BSA, median (IQR) | 1.76 (1.66 ─ 1.91) |
EUROSCORE II mean (SD) | 4.101 (0.9–14.2) |
EF (Ejection Fraction of Left Ventricle) %, mean (SD) | 51.9 (10.3) |
Valve size | |
Small | 29 (14.1) |
Medium | 84 (41.0) |
Large | 59 (28.8) |
Extra large | 33 (16.1) |
Disease | |
Aortic valve stenosis | 185 (90.2) |
Coronary artery disease | 62 (30.2) |
Mixed valvulopathy | 18 (8, 7) |
Aortic insufficiency | 4 (1, 9) |
Left main artery disease | 7 (3.4) |
Surgery | |
AVR (Aortic Valve Replacement) | 137 (66.8) |
Full sternotomy (Isolated AVR) | 28 (21,5% of isolated AVR) |
Mini sternotomy (Isolated AVR) | 109 (79,5% of isolated AVR) |
AVR + CABG (Coronary Artery Bypass Grafting) | 63 (30.7) |
Other (2 AVR + Mitral Valve Repair, 2 AVR + CABG + Mitral Valve Repair, 1 AVR + Mitral Valve Replacement) | 5 (2.4) |
Total procedural time min, mean (SD) | 186.9 (77.9) |
CPB (Cardiopulmonary Bypass) time min, mean (SD) | 108.3 (63.5) |
CPB time isolated AVR time min, mean (SD) | 59.1 (15.3 |
Ischemia time min, mean (SD) | 68.2 (61.5) |
Ischemia time for isolated AVR time min, mean (SD) | 49.1(13.4) |
Lowest temperature, mean (SD) | 32.7 (4.2) |
Cell SAVER, mean (SD) | 627.3 (259.6) |
Mean Follow-up years (SD) | 6.7 (2.3–9.4) |